TY - JOUR
T1 - Jalili Syndrome
T2 - Cross-sectional and Longitudinal Features of Seven Patients With Cone-Rod Dystrophy and Amelogenesis Imperfecta
AU - Hirji, Nashila
AU - Bradley, Patrick D.
AU - Li, Shuning
AU - Vincent, Ajoy
AU - Pennesi, Mark E.
AU - Thomas, Akshay S.
AU - Heon, Elise
AU - Bhan, Aparna
AU - Mahroo, Omar A.
AU - Robson, Anthony
AU - Inglehearn, Chris F.
AU - Moore, Anthony T.
AU - Michaelides, Michel
N1 - Funding Information:
Funding/Support: This work was supported by grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology, Fight For Sight (UK), Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity, the Wellcome Trust (grant number 206619/Z/17/Z), the Foundation Fighting Blindness (FFB; USA) FFB CD-NMT-09140659 (M.E.P.), Research to Prevent Blindness (USA) (Unrestricted Grant to Casey Eye Institute), and Retinitis Pigmentosa Fighting Blindness P30 EY010572 (Casey Eye Institute). Financial Disclosures: Mark E. Pennesi serves on the executive advisory committee for the Foundation Fighting Blindness Clinical Research Institute (these relationships have been reviewed and managed by Oregon Health & Science University). The following authors have no financial disclosures: Nashila Hirji, Patrick D. Bradley, Shuning Li, Ajoy Vincent, Akshay S. Thomas, Elise Heon, Aparna Bhan, Omar A. Mahroo, Anthony Robson, Chris F. Inglehearn, Anthony T. Moore, and Michel Michaelides. The authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2018 The Authors
PY - 2018/4
Y1 - 2018/4
N2 - Purpose: To characterize a series of 7 patients with cone-rod dystrophy (CORD) and amelogenesis imperfecta (AI) owing to confirmed mutations in CNNM4, first described as “Jalili Syndrome.” Design: Retrospective observational case series. Methods: Seven patients from 6 families with Jalili Syndrome were identified at 3 tertiary referral centers. We systematically reviewed their available medical records, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence imaging (FAF), color fundus photography, and electrophysiological assessments. Results: The mean age at presentation was 6.7 years (range 3-16 years), with 6 male and 1 female patient. CNNM4 mutations were identified in all patients. The mean Snellen best-corrected visual acuity (BCVA) at presentation was 20/246 (range 20/98 to 20/399) in the right eye and 20/252 (range 20/98 to 20/480) in the left. Nystagmus was observed in all 7 patients, and photophobia was present in 6. Funduscopic findings at presentation were variable, ranging from only mild disc pallor to retinal vascular attenuation and macular atrophy. Multimodal imaging demonstrated disease progression in all 7 patients over time. Electroretinography uniformly revealed progressive cone-rod dysfunction. Conclusions: Jalili Syndrome is a rare CORD associated with AI. We have further characterized its ocular phenotype, including describing SD-OCT, FAF, and electrophysiological features; and report several novel disease-causing sequence variants. Moreover, this study presents novel longitudinal data demonstrating structural and functional progression over time, allowing better informed advice on prognosis.
AB - Purpose: To characterize a series of 7 patients with cone-rod dystrophy (CORD) and amelogenesis imperfecta (AI) owing to confirmed mutations in CNNM4, first described as “Jalili Syndrome.” Design: Retrospective observational case series. Methods: Seven patients from 6 families with Jalili Syndrome were identified at 3 tertiary referral centers. We systematically reviewed their available medical records, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence imaging (FAF), color fundus photography, and electrophysiological assessments. Results: The mean age at presentation was 6.7 years (range 3-16 years), with 6 male and 1 female patient. CNNM4 mutations were identified in all patients. The mean Snellen best-corrected visual acuity (BCVA) at presentation was 20/246 (range 20/98 to 20/399) in the right eye and 20/252 (range 20/98 to 20/480) in the left. Nystagmus was observed in all 7 patients, and photophobia was present in 6. Funduscopic findings at presentation were variable, ranging from only mild disc pallor to retinal vascular attenuation and macular atrophy. Multimodal imaging demonstrated disease progression in all 7 patients over time. Electroretinography uniformly revealed progressive cone-rod dysfunction. Conclusions: Jalili Syndrome is a rare CORD associated with AI. We have further characterized its ocular phenotype, including describing SD-OCT, FAF, and electrophysiological features; and report several novel disease-causing sequence variants. Moreover, this study presents novel longitudinal data demonstrating structural and functional progression over time, allowing better informed advice on prognosis.
UR - http://www.scopus.com/inward/record.url?scp=85042353114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042353114&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2018.01.029
DO - 10.1016/j.ajo.2018.01.029
M3 - Article
C2 - 29421294
AN - SCOPUS:85042353114
SN - 0002-9394
VL - 188
SP - 123
EP - 130
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -